News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

NovImmune SA Appoints Andrew J. Oakley As CFO



3/12/2014 6:59:10 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Swiss biotech company Novimmune (IPO-NOVI.S), seen as a potential IPO candidate, said on Wednesday it has appointed former Actelion CFO Andrew J. Oakley as its new finance chief.

Oakley, a UK and Australian citizen who was CFO of Actelion for a decade, stepped down from the company last August to focus on other opportunities.

Help employers find you! Check out all the jobs and post your resume.

Read at Reuters


comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES